Alimera Sciences resubmits new drug application
Links shared publicly online about this topic.
- 289total visits
Alimera Sciences resubmits new drug application
View full resource at osnsupersite.com
Most Recently Shared on May 17, 2011 at 6:00 am By:
#Alimera Sciences resubmits new drug application: http://ht.ly/4VALZ
Alimera receives FDA CRL for ILUVIEN NDA
news-medical.net — “pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, including the investigational drug ILUVIEN® for the treatment of Diabetic Macular Edema (DME), today announced that Alimera Sciences, Inc, pSivida's collaborative partner, received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ILUVIEN. The FDA issued the CRL to communicate its decision that” View full resource at news-medical.net
Most Recently Shared on December 24, 2010 at 8:27 am By:
Alimera receives FDA CRL for ILUVIEN NDA: pSivida Corp., a leader in developing sustained release, drug delivery... http://bit.ly/hnuJBP
pSivida announces FDA Priority Review status for Iluvien NDA
news-medical.net — “pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has been notified that the U.S. Food and Drug Administration (FDA) has granted Priority Review status for the New Drug Application (NDA) filed for Iluvien for the treatment diabetic macular edema (DME).” View full resource at news-medical.net
Most Recently Shared on August 31, 2010 at 1:26 pm By:
pSivida announces FDA Priority Review status for Iluvien NDA: pSivida Corp., a leader in the development of sustai... http://bit.ly/8YNXRu
Alimera Sciences requests priority review of intravitreal insert for DME
osnsupersite.com — “ATLANTA — Alimera Sciences has submitted a new drug application to the U.S. Food and Drug Administration requesting a priority review of its” View full resource at osnsupersite.com
Most Recently Shared on June 29, 2010 at 3:40 pm By:
Alimera Sciences requests priority review of intravitreal insert for DME: http://ht.ly/24Lg5 — #ophthalmology #business #news
Advertisement
